In other sections, the conference will concentrate on strategies and efforts for investigator-initiated and academic clinical research. Clinicians, researchers, and professionals from research institutes, as well as policymakers, industry, and regulatory organizations, will attend the conference. The agenda will provide the framework for future success in investigator-initiated studies by addressing existing challenges and showing innovative solutions.
As a consequence of popular demand, the conference, which is oriented toward pharmaceutical and medical device companies, will include more legal problems surrounding external physician collaboration, a stronger focus on ROI, and more speakers from the pharmaceutical industry. The conference will include a small-group format to foster peer-to-peer networking and conversation among industry professionals, as well as specialized courses for pharmaceutical and medical device companies of all sizes.
For more information, please visit https://dgevents.com/event/investigator-initiated-trials-summit/.